News

November 14, 2016 - CalciMedica Announces Senior Clinical Development Hire Read More

November 10, 2016 - DalCor Announces Data to be Presented at the American Heart Association Scientific Sessions 2016 in New Orleans Read More

November 4, 2016 - ViaCyte to Present at Healthcare Events in November Read More

October 19, 2016 - Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis for Childhood Developmental Delay Read More

October 11, 2016 - ViaCyte to Present at Healthcare Events in October Read More

October 4, 2016 - Altor BioScience Corporation and NantKwest Inc. Announce Co-Development Agreement to Advance Innovative Natural Killer Cell Combination Immunotherapies for the Treatment of Cancer Read More

October 3, 2016 - THVD-102 Demonstrates Promising Potential as an Orally Administered Treatment for Hyperhidrosis Read More

October 3, 2016 - ViaCyte to Provide a Corporate Update at 2016 Cell and Gene Meeting on the Mesa Read More

September 9, 2016 - ViaCyte to Speak on Diabetes Panel at BioPharm America 2016 Read More

August 23, 2016 - DalCor Announces Opening of International Trial Sites for Its Dal-GenE Phase 3 Cardiovascular Outcomes Trial Read More